Suppr超能文献

威斯康星步态量表 - 最小临床重要差异。

The Wisconsin gait scale - The minimal clinically important difference.

作者信息

Guzik Agnieszka, Drużbicki Mariusz, Wolan-Nieroda Andżelina, Przysada Grzegorz, Kwolek Andrzej

机构信息

Institute of Physiotherapy, Medical Faculty, University of Rzeszow, Hoffmanowej 25, 35-310 Rzeszów, Poland; Centre for Innovative Research in Medical and Natural Sciences, University of Rzeszow, Warzywna 1a, 35-310 Rzeszów, Poland.

出版信息

Gait Posture. 2019 Feb;68:453-457. doi: 10.1016/j.gaitpost.2018.12.036. Epub 2018 Dec 26.

Abstract

BACKGROUND

Wisconsin Gait Scale (WGS) is an observational tool for the evaluation of gait quality in individuals after stroke with hemiplegia. It is divided into four subscales, which assess a total of fourteen spatiotemporal and kinematic parameters of gait observed during the consecutive gait phases. However, the WGS score change indicative of important and clinically meaningful change has not been determined.

RESEARCH QUESTION

The study has been designed to define the minimal clinically important difference (MCID) of the WGS.

METHODS

Four methods were used to determine the MCID for the WGS in 50 participants who had experienced a stroke: anchor-based study, distribution-based study, linear regression analysis and specification of the receiver operating characteristic (ROC) curve.

RESULTS

In the anchor-based study, the mean change score in the MCID group was 1.9 points (the first MCID estimate). In the distribution-based study, the standard error of measurement for the no-change group was 0.3 (the second MCID estimate). The slope of the regression line was 1.21 which means than 1-point change in the Barthel Index (BI) is associated with 1.21-point change in the WGS. This translates to 2.25 points change in the WGS with 1.85 points change in the BI (the third MCID estimate). The best cut-off point, determined with ROC curve, was the value corresponding to 1 point of change in the WGS (the fourth MCID estimate).

SIGNIFICANCE

We established that the MCID of the WGS was 2.25 points, based on the largest of the four MCID estimates. The value 2.25 of the MCID can help clinicians and researchers determine if the change in the scores on the WGS is clinically important.

CLINICAL TRIAL REGISTRATION

Data are parts of the following clinical trial: ACTRN12617000436370.

摘要

背景

威斯康星步态量表(WGS)是一种用于评估偏瘫性脑卒中患者步态质量的观察工具。它分为四个子量表,共评估连续步态阶段观察到的14个步态时空和运动学参数。然而,尚未确定表明重要且具有临床意义变化的WGS评分变化。

研究问题

本研究旨在确定WGS的最小临床重要差异(MCID)。

方法

采用四种方法确定50例脑卒中患者WGS的MCID:基于锚定的研究、基于分布的研究、线性回归分析和受试者操作特征(ROC)曲线的确定。

结果

在基于锚定的研究中,MCID组的平均变化评分为1.9分(第一个MCID估计值)。在基于分布的研究中,无变化组的测量标准误为0.3(第二个MCID估计值)。回归线的斜率为1.21,这意味着Barthel指数(BI)变化1分与WGS变化1.21分相关。这相当于BI变化1.85分,WGS变化2.25分(第三个MCID估计值)。用ROC曲线确定的最佳截断点是WGS变化1分对应的数值(第四个MCID估计值)。

意义

基于四个MCID估计值中的最大值,我们确定WGS的MCID为2.25分。MCID值2.25可帮助临床医生和研究人员确定WGS评分的变化在临床上是否重要。

临床试验注册

数据是以下临床试验的一部分:ACTRN12617000436370。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验